Medifocus Inc. (CVE:MFS)’s stock price traded up 100% on Thursday . The company traded as high as C$0.01 and last traded at C$0.01, 540,000 shares were traded during mid-day trading. An increase of 24% from the average session volume of 436,212 shares. The stock had previously closed at C$0.01.
The stock has a 50-day moving average price of C$0.01. The firm has a market capitalization of $1.85 million and a price-to-earnings ratio of -0.50.
Medifocus Company Profile (CVE:MFS)
Medifocus Inc, a medical technology company, develops and commercializes minimally invasive focused heat systems for the treatment of cancerous and benign tumors, and enlarged prostate in Canada and the United States. The company owns technology platforms, including Endo-thermotherapy platform, a catheter-based focused heat technology platform that utilizes natural body openings to deliver microwave thermotherapy to the diseased sites; and Adaptive Phased Array (APA) Microwave Focusing platform, which directs focused microwave energy at tumor center to induce shrinkage or eradication of tumors without undue harm to surrounding tissue.
Recommended Story: Balanced Fund
Receive News & Ratings for Medifocus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medifocus and related companies with MarketBeat.com's FREE daily email newsletter.